Amorchem logo

Amorchem

North America, Quebec, Canada, Montréal

Description

A venture capital fund located in Montreal focused on creating promising life science companies.

Investor Profile

Amorchem has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series C, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in Canada.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.

Stage Focus

  • Seed (33%)
  • Series C (17%)
  • Post Ipo Equity (17%)
  • Series A (17%)
  • Series B (17%)

Country Focus

  • Canada (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Amorchem frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 3
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Accel-Rx Health Sciences Accelerator
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
AQC Capital
North America, Quebec, Canada, Montréal
Co-Investments: 3
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 2
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 3
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 4
adMare Bio Innovations
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
Anges Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 2

What are some of recent deals done by Amorchem?

Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series COct 17, 2022
Amount Raised: $69,264,701
Giiant Pharma

Montréal, Quebec, Canada

Giiant Pharma is a preclinical-stage biotech company.

BiopharmaBiotechnologyHealth CareLife Science
SeedMay 21, 2021
Amount Raised: $12,429,875
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BSep 8, 2020
Amount Raised: $35,000,000
Liminal BioSciences

Laval, Quebec, Canada

Liminal is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products.

BiotechnologyHealth DiagnosticsMedical
Post Ipo EquityJul 16, 2020
Amount Raised: $1,768,199
Inversago Pharma

Montréal, Quebec, Canada

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series AJul 25, 2018
Amount Raised: $7,000,000
SpecificiT Pharma

Montréal, Quebec, Canada

A privately held biopharmaceutical company.

BiotechnologyHealth CarePharmaceutical
SeedSep 11, 2017

Find More Investors Like Amorchem

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Amorchem | Pipeseed